Dr. Chlebowski on How Weight Loss Improves TNBC Survival

Rowan Chlebowski, MD, PhD
Published: Tuesday, Dec 16, 2014



As few as five pounds of weight loss can make a significant difference for patients with triple-negative breast cancer, says Rowan Chlebowski, MD, PhD, a medical oncologist at the Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center.

Among patients following a program to reduce their dietary fat intake, those with estrogen receptor (ER)-negative breast cancer had a reduction of death of 36%, while ER- and progesterone receptor (PR)-negative patients had a 54% reduction of death compared to the control group.

Losing even a small amount of weight can impact factors that drive tumor growth like glucose metabolism, inflammatory factors, and diabetes, says Chlebowski.

More research is needed to validate these findings from a scientific standpoint, but because five pounds of weight loss is such a simple change, Chlebowski suggests breast cancer patients put it into practice now.

<<< View more from the 2014 San Antonio Breast Cancer Symposium



As few as five pounds of weight loss can make a significant difference for patients with triple-negative breast cancer, says Rowan Chlebowski, MD, PhD, a medical oncologist at the Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center.

Among patients following a program to reduce their dietary fat intake, those with estrogen receptor (ER)-negative breast cancer had a reduction of death of 36%, while ER- and progesterone receptor (PR)-negative patients had a 54% reduction of death compared to the control group.

Losing even a small amount of weight can impact factors that drive tumor growth like glucose metabolism, inflammatory factors, and diabetes, says Chlebowski.

More research is needed to validate these findings from a scientific standpoint, but because five pounds of weight loss is such a simple change, Chlebowski suggests breast cancer patients put it into practice now.

<<< View more from the 2014 San Antonio Breast Cancer Symposium


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x